TD Cowen analyst Joe Thome reiterated a Buy rating on G1 Therapeutics (NASDAQ: GTHX).The analyst commented, "G1 announced that the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE